Is it time for pharmacovigilance teams to utilize AI applications to improve adverse event reporting?
As you consider more efficient approaches for monitoring, searching, and distributing results to the pharmacovigilance team, here’s one information manager’s advice.
‘1201’ exceptions are a topic of considerable discussion every few years. As it turns out, 2018 is one of those years.
Conversations about “digital transformation” often the focus is on technology investments, talent and changing business processes. Relatively less attention falls on the organization that must fulfill the chosen digital strategies.
Join CCC for a special presentation at Bio-IT World in Boston on May 16 – we’ll be discussing ontology learning and personalization.
We’ll be at Booth #333 at the Association for Talent Development International Conference and Exposition in San Diego. Discover learning solutions for your organization.
The FDA’s 2019 budget request is $5.8 billion. Here’s a look at what Commissioner Scott Gottlieb plans to do with the funds.